Tetsuya Okayama
Overview
Explore the profile of Tetsuya Okayama including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
82
Citations
1213
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yoshida N, Kuriu Y, Ikeda J, Kudou M, Kirishima T, Okayama T, et al.
Int J Clin Oncol
. 2023 Aug;
28(10):1378-1387.
PMID: 37578664
Background: Trifluridine/tipiracil (TAS-102) is an anticancer drug for metastatic colorectal cancer (CRC). This study aimed to analyze the effects and risk factors about effects of TAS-102 in real-world patients with...
2.
Okano F, Harusato A, Tokuda B, Taketani H, Ishiba H, Fukui A, et al.
Nihon Shokakibyo Gakkai Zasshi
. 2023 Mar;
120(3):269-275.
PMID: 36908146
This is a case report of fascioliasis that progressed from the hepatic to the biliary phases over 2 years. A woman in her late 60s ate Zingiber mioga from the...
3.
Minagawa Y, Uchiyama K, Takagi T, Mizushima K, Asaeda K, Kajiwara-Kubota M, et al.
J Clin Biochem Nutr
. 2022 Nov;
71(3):249-254.
PMID: 36447487
Mesalamine is a key drug in the treatment of ulcerative colitis (UC) for both induction and maintenance therapy. On the other hand, it is known that there are some cases...
4.
Endo Y, Ishikawa T, Oka K, Sakakida T, Matsumura S, Mizushima K, et al.
Med Oncol
. 2022 Jun;
39(8):110.
PMID: 35666320
Granulocyte-colony stimulating factor (G-CSF) stimulates bone marrow progenitor cell proliferation and enhances neutrophil production. Exogenous G-CSF administration is indicated for chemotherapy-induced neutropenia management. However, there is a paucity of basic...
5.
Uchiyama K, Takagi T, Mizushima K, Asaeda K, Kajiwara M, Kashiwagi S, et al.
Dig Dis Sci
. 2022 May;
67(10):4760-4769.
PMID: 35590045
Background: Recent progress in ulcerative colitis (UC) treatment has been remarkable, and various medications have been applied. However, some patients with UC are refractory to treatment and convert to surgery....
6.
Nagata Y, Kageyama S, Ishikawa T, Kokura S, Okayama T, Abe T, et al.
Cancer Immunol Immunother
. 2022 Apr;
71(11):2743-2755.
PMID: 35429246
The aim of this study was to determine the efficacy and the biomarkers of the CHP-NY-ESO-1 vaccine complexed with full-length NY-ESO-1 protein and a cholesteryl pullulan (CHP) in patients with...
7.
Takagi T, Okayama T, Asai J, Mizushima K, Hirai Y, Uchiyama K, et al.
Biochem Pharmacol
. 2022 Mar;
199:115016.
PMID: 35331735
Clinical incidences of pressure ulcers in the elderly and intractable skin ulcers in diabetic patients are increasing because of the aging population and an increase in the number of diabetic...
8.
Katada K, Takagi T, Iida T, Ueda T, Mizushima K, Fukui A, et al.
Antioxidants (Basel)
. 2022 Mar;
11(3).
PMID: 35326209
Intestinal ischemia-reperfusion (IR) injury is a complex, multifactorial, and pathophysiological condition with high morbidity and mortality, leading to serious difficulties in treatment, especially in humans. Heme oxygenase (HO) is the...
9.
Uchiyama K, Takagi T, Mizushima K, Asaeda K, Kajiwara M, Kashiwagi S, et al.
J Gastroenterol Hepatol
. 2022 Mar;
37(6):1034-1042.
PMID: 35233808
Background And Aim: Complete endoscopic mucosal healing is defined as a Mayo endoscopic subscore of 0. Some patients diagnosed with a Mayo endoscopic subscore 0 may present with subsequent clinical...
10.
Sakakida T, Ishikawa T, Doi T, Morita R, Endo Y, Matsumura S, et al.
Cancer Sci
. 2022 Feb;
113(5):1789-1800.
PMID: 35201655
Cancer cachexia and the associated skeletal muscle wasting are considered poor prognostic factors, although effective treatment has not yet been established. Recent studies have indicated that the pathogenesis of skeletal...